Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in
  • Log out

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
  • Log out
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Kidney Failure

  • You have access
    Drugs for the prevention and treatment of acute renal failure
    Frank Cosentino, DO
    Cleveland Clinic Journal of Medicine July 1995, 62 (4) 248-253;

    Mannitol, loop diuretics, dopamine, and calcium antagonists show promise, but they have not yet been rigorously tested for this indication. Caution is advised.

  • You have access
    Potential molecular therapy for acute renal failure
    H. David Humes, MD
    Cleveland Clinic Journal of Medicine March 1993, 60 (2) 166-168;

    As more is learned about renal epithelial cell regeneration and differentiation, exogenously administered growth promoters seem a likely intervention.

  • You have access
    Benign intracranial hypertension and chronic renal failure
    Douglas Chang, MD, Gary Nagamoto, MD and William E. Smith, MD
    Cleveland Clinic Journal of Medicine July 1992, 59 (4) 419-422;

    Chronic renal failure of unknown etiology is described in a patient with new-onset headache, papilledema, and intracranial pressures between 200 and 400 mm H2O.

  • You have access
    The anemia of chronic renal failure
    Emil P. Paganini, MD, FACP, José Garcia, MD, Mohamed Abdulhadi, MD, Deborah Lathim, RN, Joan Giesman, RN and James K. Weick, MD
    Cleveland Clinic Journal of Medicine January 1989, 56 (1) 79-86;
  • You have access
    Cardiovascular disease in patients with chronic renal failure
    Richard C. Becker, MD
    Cleveland Clinic Journal of Medicine November 1988, 55 (6) 521-530;
  • You have access
    Primary hyperoxaluria
    Donald R. Steinmuller, M.D.
    Cleveland Clinic Journal of Medicine March 1985, 52 (1) 27-30;

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire